Complete Story
 

06/21/2013

Adding Bevacizumab to Chemotherapy Improves Survival in Advanced Cervical Cancer

Adding bevacizumab (Avastin) to chemotherapy regimens with or without a platinum drug improved outcomes for women with metastatic or relapsed cervical cancer treated in a randomized phase III study.  READ MORE


< Back | Printer Friendly Page